AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2022
May 11, 2022
32853_dirs_2022-05-10_c0fc4a02-1794-4164-a83a-b7ca5d8a6e32.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-05-06
Reporting Person: Caligan Partners LP (10% Owner)
Reporting Person: JOHNSON DAVID EDWARD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-06 | Common Stock, $0.001 par value per share (Common Stock) | P | 463350 | $2.90 | Acquired | 9948188 | Indirect |
| 2022-05-10 | Common Stock | P | 25000 | $2.52 | Acquired | 9973188 | Indirect |
Footnotes
F1: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson (together with Caligan, the "Reporting Persons") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F2: The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.